- About Us
- Nano-Social Network
- Nano Consulting
- My Account
August 14th, 2007
Promising new nanomedical cancer therapy also highlights tech transfer
If a new approach to cancer therapy, still experimental and in a phase I clinical trial, turns out as well as hoped, the credit will go as much to technology transfer as to scientific acumen.
That's the opinion of Mark Davis, the Schlinger Professor of Chemical Engineering at the California Institute of Technology. Davis's custom-designed nanoparticles for fighting cancer are currently being tested on patients at City of Hope in nearby Duarte, and are now in the planning stages for more extensive phase II trials. The nanoparticles are built to deliver chemotherapy drugs to tumors in such a way that the adverse effects of the drugs on the rest of the body are minimized.
|Related News Press|
New active filaments mimic biology to transport nano-cargo: A new design for a fully biocompatible motility engine transports colloidal particles faster than diffusion with active filaments January 11th, 2017
Call for NanoArt and Art-Science-Technology Papers June 9th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016